Top 20 Genomics Companies in the World
- Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
- CRISPR Therapeutics AG (NASDAQ:CRSP)
- Krystal Biotech, Inc.
- Blueprint Medicines Corporation (NASDAQ:BPMC)
- Intellia Therapeutics, Inc.
- Pacific Biosciences of California, Inc.
- Genus plc (LON:GNS.
- Beam Therapeutics Inc.
James Watson and Francis Crick discovered the double helix structure of DNA in 1953. In 1961, Marshall Nirenberg and Har Gobind Khorana led the research team that identified what is now known as the “codon” of DNA. This is the block of three letters in DNA that correlates to a specific amino acid.We are a global genomics and human health leader innovating the future of precision health. We develop DNA sequencing and array-based life sciences technologies to enable boundless research discovery and personalized health.
How did genomics start : Pinpointing the exact beginning of comparative genomics may be difficult. In a sense, one may say that it was born as soon as there were two genomes to compare, i.e. in 1977 when the genome of phage ϕX174 was sequenced and could be compared with the already available sequence of the RNA phage MS2.
What countries are leading in genomics
the US
majority of publicly traded and privately held genomics firms in our database were in the US; 75% and 62%, re- spectively. Canada, Germany, France, United Kingdom, and Japan rounded out the top six countries (see Table 1).
Who is the CEO of genomic life : Randy Scott, Ph. D., Chairman and CEO of Genomic Life, is a scientist, entrepreneur and co-founder of multiple biotechnology companies. Randy is currently CEO of Thinking Bench Capital, LLC and Chair and Co-founder of Genome Medical, a nationwide tele-genetics medical practice founded in 2016.
The most active investors in the genomic space are a fairly diverse group and come from both the tech and biotech sides. Among the top investors, there are both biotech and tech accelerators (IndieBio and Y Combinator), health and tech corporates (Roche and Google Ventures), and traditional venture firms.
Jacob Thaysen
Illumina's search for a CEO is complete. The gene-sequencing company announced that it has tapped Agilent's Jacob Thaysen to take the helm.
Who competes with Illumina
Illumina's competitors and similar companies include Qiagen, Luminex, BGI Genomics, Thermo Fisher Scientific, Bruker and Natera.Rahul Ranganathan
Founded in 2019, Answer Genomics is led by Rahul Ranganathan as CEO, a Molecular Biologist from Delhi University, and an MBA from XLRI Jamshedpur with experience across organisations like PepsiCo and Flipkart. Dr. Balamurali AR serves as the CTO and is a Ph. D.THE ONGOING GENOMICS revolution, highlighted by the sequencing of the human genome, promises to change how diseases are diagnosed, prevented, and treated. It has tremendous potential to improve health globally.
Scholars from the United States are dominating the ranking with 546 scientists representing 54.6% of all leading genetics & molecular biology scientists. 6 out of 10 scientists in the top 1% are from the United States, with the other countries represented being Finland, Iceland, the UK, and France.
Which country is leading in genetic research : Scholars from the United States dominate the list, with 491 profiles included in our 2023 report. Harvard University takes the top position among leading institutions for genetics science research, with 36 affiliated scholars in this year's report.
Who runs Genomics England : Genomics England is a British company set up and owned by the United Kingdom Department of Health and Social Care to run the 100,000 Genomes Project.
Who is the CEO of 10x Genomics
Serge Saxonov co-founded 10x Genomics in 2012. As the CEO, he defined the 10x vision and strategy, contributed to core inventions, and has led the company since inception.
NASDAQ: ILMN
Illumina is the industry leader in using short-read sequencing technology, which breaks DNA into short segments to aid in analysis for genetic research, testing, and medical treatment. With an installed base of more than 20,000 sequencing systems, Illumina holds around 80% of the global market.Francis deSouza has resigned as the CEO of Illumina weeks after surviving Carl Icahn's attempt to oust him as a director of the company. Late last month, deSouza chalked up a partial victory in a proxy vote that served as a referendum on his time as CEO and on the move to acquire liquid biopsy company Grail.
Did Roche buy Illumina : In 2012, Roche attempted a $6.8 billion hostile takeover of Illumina, but the deal never came together. The next year Roche said it abandoned its attempts because Illumina's asking price was “unrealistic.”